Aurobindo Pharma’s Unit 7 is estimated to house over 150 cumulative ANDA filings (20% of the US portfolio). Previous Post Apollo Hospitals shares may rally 33% from current levels; Citi cites attractive valuations Next Post Q3 Results Live Updates: Brokerages give 'buy' rating to Eicher Motors, Britannia; Lenskart, M&M in focus Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
